Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides
Amir Pandi(Centre National de la Recherche Scientifique), Tobias J. Erb(Loewe Center for Synthetic Microbiology)
Cited by 10
Related Papers
A short history of RubisCO: the rise and fall (?) of Nature's predominant CO2 fixing enzyme
|Current Opinion in Biotechnology|2017|336
Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides
|Nature Communications|2023|141
A versatile active learning workflow for optimization of genetic and metabolic networks
|Nature Communications|2022|132